Table 1. Characteristics of subjects with (FLD) and without (non-FLD) FLD (age-adjusted) (n = 4053).
| Women(n = 1617) | Men(n = 2436) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Variables | FLD | (n = 263) | non-FLD | (n = 1354) | FLD | (n = 790) | non-FLD | (n = 1646) | ||
| Continuous data | Mean | SD | Mean | SD | P1 | Mean | SD | Mean | SD | P1 |
| Age, years | 51.0 | 10.0 | 43.5 | 11.3 | <0.001 | 46.0 | 11.1 | 45.6 | 13.1 | 0.492 |
| Height, cm | 158.0 | 5.5 | 158.2 | 5.4 | 0.015 | 169.7 | 5.7 | 169.3 | 5.9 | 0.080 |
| Weight, kg | 63.16 | 9.06 | 55.42 | 7.37 | <0.001 | 76.31 | 9.17 | 67.35 | 8.86 | <0.001 |
| Neck circumference, cm | 34.15 | 2.40 | 32.13 | 2.05 | <0.001 | 38.79 | 2.36 | 36.72 | 2.23 | <0.001 |
| Waist circumference, cm | 84.29 | 8.52 | 74.72 | 8.11 | <0.001 | 92.23 | 7.16 | 83.66 | 7.99 | <0.001 |
| Hip circumference, cm | 96.80 | 6.42 | 92.08 | 5.59 | <0.001 | 99.66 | 5.52 | 95.00 | 5.45 | <0.001 |
| Body mass index, kg/m2 | 25.29 | 3.24 | 22.15 | 2.78 | <0.001 | 26.47 | 2.61 | 23.47 | 2.65 | <0.001 |
| Waist/hip ratio | 0.87 | 0.06 | 0.81 | 0.06 | <0.001 | 0.93 | 0.05 | 0.88 | 0.05 | <0.001 |
| Systolic blood pressure, mmHg | 130.7 | 19.5 | 116.3 | 17.3 | <0.001 | 129.6 | 16.1 | 122.8 | 15.9 | <0.001 |
| Diastolic blood pressure, mmHg | 78.4 | 10.8 | 71.6 | 10.3 | <0.001 | 82.0 | 11.7 | 76.4 | 11.0 | <0.001 |
| Triglycerides, mmol/L | 1.79 | 1.19 | 1.14 | 0.83 | <0.001 | 2.41 | 1.64 | 1.51 | 1.08 | <0.001 |
| Total cholesterol, mmol/L | 5.90 | 1.15 | 5.43 | 1.05 | <0.001 | 5.82 | 1.19 | 5.47 | 1.02 | <0.001 |
| High density lipoprotein, mmol/L | 1.37 | 0.33 | 1.55 | 0.38 | <0.001 | 1.15 | 0.28 | 1.29 | 0.38 | <0.001 |
| Low density lipoprotein, mmol/L | 3.65 | 0.98 | 3.27 | 0.92 | 0.004 | 3.61 | 0.99 | 3.46 | 0.95 | <0.001 |
| Fasting blood glucose, mmol/L | 5.32 | 1.22 | 4.81 | 0.62 | <0.001 | 5.36 | 1.47 | 4.94 | 1.02 | <0.001 |
| Blood uric acid, μmol/L | 272.2 | 79.4 | 215.0 | 64.2 | <0.001 | 359.0 | 85.7 | 314.0 | 74.8 | <0.001 |
| Apolipoprotein A, g/L | 1.31 | 0.33 | 1.39 | 0.40 | 0.002 | 1.17 | 0.36 | 1.20 | 0.29 | 0.073 |
| Apolipoprotein B, g/L | 0.99 | 0.23 | 0.87 | 0.23 | <0.001 | 1.00 | 0.24 | 0.93 | 0.30 | <0.001 |
| Apolipoprotein E, g/L | 47.26 | 14.66 | 42.28 | 12.38 | <0.001 | 48.87 | 16.40 | 40.69 | 12.64 | <0.001 |
| Aspartate transaminase 3 , U/L | 22.0 | (20.0–27.0) | 20.0 | (17.0–22.0) | <0.001 | 26.0 | (22.0–33.0) | 22.0 | (22.0–26.0) | <0.001 |
| Alanine transaminase 3 , U/L | 21.0 | (15.0–31.0) | 15.0 | (11.0–19.0) | <0.001 | 34.0 | (23.0–48.0) | 21.0 | (16.0–28.0) | <0.001 |
| γ-glutamyl transpeptidase 3 , U/L | 24.0 | (18.0–34.5) | 17.0 | (13.0–22.0) | <0.001 | 44.0 | (30.8–65.0) | 27.0 | (20.0–39.0) | <0.001 |
| Categorical data | n | % | n | % | P2 | n | % | n | % | P2 |
| Diabetes 4 | 20 | 7.60 | 27 | 1.99 | <0.001 | 83 | 10.51 | 59 | 3.58 | <0.001 |
| Overweight 5 | 172 | 65.40 | 301 | 22.23 | <0.001 | 668 | 84.56 | 695 | 42.22 | <0.001 |
| Central obesity 6 | 190 | 72.24 | 331 | 24.45 | <0.001 | 480 | 60.76 | 369 | 22.42 | <0.001 |
P 1: Covariance analysis adjusted for age
P 2: Wald chi-square test adjusted for age
3: Median (percentile 25, 75). Logarithmic transformation before analysis
4: Diabetes was defined as fasting plasma glucose (FPG) levels ≥7.0 mmol/L or by a self-reported history of diabetes confirmed by the doctor(s).
5: Overweight was defined as a BMI ≧24 kg/m2 for both genders.
6: Central obesity was defined as a waist circumference (WC)≧80 cm in women and ≧90 cm in men.